Altimmune Inc. (ALT) up 73.40% since start of the year

Altimmune Inc. (NASDAQ: ALT) is 73.40% higher on its value in year-to-date trading and has touched a low of $1.60 and a high of $35.10 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ALT stock was last observed hovering at around $22.93 in the last trading session, with the day’s loss setting it -3.37% off its average median price target of $38.50 for the next 12 months. It is also 75.55% off the consensus price target high of $80.00 offered by 6 analysts, but current levels are 18.5% higher than the price target low of $24.00 for the same period.

The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Currently trading at $19.56, the stock is 4.41% and 29.15% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.64 million and changing -14.70% at the moment leaves the stock 37.17% off its SMA200. ALT registered 1011.36% gain for a year compared to 6-month loss of -24.97%. The firm has a 50-day simple moving average (SMA 50) of $16.61 and a 200-day simple moving average (SMA200) of $14.58.

The stock witnessed a 51.51% gain in the last 1 month and extending the period to 3 months gives it a 109.87%, and is -11.97% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.08% over the week and 12.76% over the month.

Altimmune Inc. (ALT) has around 25 employees, a market worth around $663.28M and $6.40M in sales. Distance from 52-week low is 1122.50% and -44.27% from its 52-week high. The company has generated returns on investments over the last 12 months (-47.00%).

Altimmune Inc. (ALT) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Altimmune Inc. (ALT) is a “Buy”. 6 analysts offering their recommendations for the stock have an average rating of 1.70, where 0 rate it as a Hold and 0 think it is a “Overweight”. 6 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Altimmune Inc. is expected to release its quarterly report on 05/18/2021 and quarterly earnings per share for the current quarter are estimated at -$0.75 with sales reaching $2.14M over the same period.The EPS is expected to grow by 89.50% this year, but quarterly earnings will post 32.90% year-over-year. Quarterly sales are estimated to grow 272.20% in year-over-year returns.

Altimmune Inc. (ALT) Top Institutional Holders

83 institutions hold shares in Altimmune Inc. (ALT), with 2.14M shares held by insiders accounting for 6.51% while institutional investors hold 71.98% of the company’s shares. The shares outstanding are 33.06M, and float is at 30.92M with Short Float at 8.44%. Institutions hold 67.29% of the Float.

The top institutional shareholder in the company is VR Adviser, LLC with over 4.5 million shares valued at $59.4 million. The investor’s holdings represent 13.61% of the ALT Shares outstanding. As of Sep 29, 2020, the second largest holder is Baker Brothers Advisors, LLC with 2.21 million shares valued at $29.13 million to account for 6.67% of the shares outstanding. The other top investors are Avoro Capital Advisors LLC which holds 2.0 million shares representing 6.05% and valued at over $26.4 million, while Shaw D.E. & Co., Inc. holds 5.02% of the shares totaling 1.66 million with a market value of $21.92 million.

Altimmune Inc. (ALT) Insider Activity

A total of 24 insider transactions have happened at Altimmune Inc. (ALT) in the last six months, with sales accounting for 12 and purchases happening 12 times. The most recent transaction is an insider purchase by Schafer Klaus, the company’s Director. SEC filings show that Schafer Klaus bought 2,000 shares of the company’s common stock on Dec 10 at a price of $11.99 per share for a total of $23980.0. Following the purchase, the insider now owns 8900.0 shares.

Altimmune Inc. disclosed in a document filed with the SEC on Dec 01 that Hodges Philip (Director) sold a total of 1,227 shares of the company’s common stock. The trade occurred on Dec 01 and was made at $13.54 per share for $16614.0. Following the transaction, the insider now directly holds 0.0 shares of the ALT stock.

Still, SEC filings show that on Nov 30, GILL JOHN (Director) disposed off 8,425 shares at an average price of $11.92 for $0.1 million. The insider now directly holds 11,199 shares of Altimmune Inc. (ALT).

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free